Connection

SUJITH JOSEPH to Animals

This is a "connection" page, showing publications SUJITH JOSEPH has written about Animals.
Connection Strength

0.215
  1. Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis. Vaccine. 2013 Jul 18; 31(33):3320-6.
    View in: PubMed
    Score: 0.024
  2. Anti-inflammatory BmAFI of Brugia malayi modulates IgE, histamine and histamine receptor responses in Mastomys coucha. Acta Trop. 2013 Aug; 127(2):82-6.
    View in: PubMed
    Score: 0.024
  3. Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2. Vaccine. 2012 Oct 05; 30(45):6477-82.
    View in: PubMed
    Score: 0.023
  4. IgG subclass responses to proinflammatory fraction of Brugia malayi in human filariasis. Indian J Med Res. 2012 May; 135(5):650-5.
    View in: PubMed
    Score: 0.022
  5. Sensitization with anti-inflammatory BmAFI of Brugia malayi allows L3 development in the hostile peritoneal cavity of Mastomys coucha. Acta Trop. 2011 Dec; 120(3):191-205.
    View in: PubMed
    Score: 0.021
  6. A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function. Cancer Res Commun. 2025 Mar 01; 5(3):527-548.
    View in: PubMed
    Score: 0.014
  7. A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma. Sci Transl Med. 2021 05 05; 13(592).
    View in: PubMed
    Score: 0.010
  8. Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med. 2020 05; 26(5):720-731.
    View in: PubMed
    Score: 0.010
  9. CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression. Leukemia. 2021 01; 35(1):75-89.
    View in: PubMed
    Score: 0.010
  10. Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma. Neuro Oncol. 2018 03 27; 20(4):506-518.
    View in: PubMed
    Score: 0.008
  11. Cross reactive molecules of human lymphatic filaria Brugia malayi inhibit Leishmania donovani infection in hamsters. Acta Trop. 2015 Dec; 152:103-111.
    View in: PubMed
    Score: 0.007
  12. Protection against filarial infection by 45-49 kDa molecules of Brugia malayi via IFN-?-mediated iNOS induction. Vaccine. 2015 Jan 15; 33(4):527-34.
    View in: PubMed
    Score: 0.007
  13. Humoral and cell-mediated immune responses elicited by poly (DL-lactide) adjuvanted filarial antigen molecules. Drug Deliv. 2014 May; 21(3):233-41.
    View in: PubMed
    Score: 0.006
  14. Plant products in the treatment and control of filariasis and other helminth infections and assay systems for antifilarial/anthelmintic activity. Planta Med. 2011 Apr; 77(6):647-61.
    View in: PubMed
    Score: 0.005
  15. Antifilarial activity in vitro and in vivo of some flavonoids tested against Brugia malayi. Acta Trop. 2010 Nov; 116(2):127-33.
    View in: PubMed
    Score: 0.005
  16. Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres. J Drug Target. 2010 Apr; 18(3):212-22.
    View in: PubMed
    Score: 0.005
  17. Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection. Vaccine. 2009 Jul 09; 27(32):4263-71.
    View in: PubMed
    Score: 0.005
  18. Influence of Brugia malayi life stages and BmAFII fraction on experimental Leishmania donovani infection in hamsters. Acta Trop. 2008 May; 106(2):81-9.
    View in: PubMed
    Score: 0.004
  19. Protection against L3 induced Brugia malayi infection in Mastomys coucha pre-immunized with BmAFII fraction of the filarial adult worm. Vaccine. 2006 Jul 26; 24(31-32):5824-31.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.